foxo4-dri senolytic peptide animal model 2023 2024

foxo4-dri senolytic peptide animal model 2023 2024 Senolytics: from pharmacological inhibitors to immunotherapies, a promising future for patients' treatment Targeting the FOXO4-p53 axis by

Name: foxo4-dri senolytic peptide animal model 2023 2024 Senolytics: from pharmacological inhibitors to immunotherapies, a promising future for patients' treatment Targeting the FOXO4-p53 axis by
Brand: msw-creativ-solutions.de
SKU: 65662539103
Price: 25.79 USD
Availability: InStock
Rating: 4.0963 (8 reviews)

Targeting the FOXO4 p53 axis by retro inverso peptide senolytic agents: a pharmacological strategy to mitigate brain aging and cognitive decline Naunyn Schmiedeberg's Archives of Pharmacology Springer Nature Link Frontiers FOXO4 DRI regulates endothelial cell senescence via the P53 signaling pathway FOXO4 DRI FOXO4 p53 Peptide Peptagon Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging PMC FOXO4 DRI part 1 #peptide #molecule #research #health #information Molecular modelling of the FOXO4 TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells ScienceDirect

SKU: 65662539103 · From msw-creativ-solutions.de

4.1

USD25.79 USD47.79

Pay in 4 interest-free payments of $6.45 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Sep 22 - Sep 27

Description

GHK Cu is a synthetic coppertripeptide complex composed of glycyl L histidyl L lysine (GHK) chelated with copper(II), used in research to study tissue remodeling, extracellular matrix regulation, and copper dependent signaling in vitro and in animal models